World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
109
Citations
44205
World Ranking
518
National Ranking
315

Medicine

D-Index
109
Citations
44377
World Ranking
5773
National Ranking
3103

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Daniel R. Kuritzkes is affiliated with Brigham and Women's Hospital in the United States. Their research spans several fields, with a primary focus on Medicine and Immunology and Microbiology. Within these broad areas, they have contributed extensively to subfields including Infectious Diseases, Virology, Molecular Biology, Immunology, and Epidemiology.

The scientist has a strong research record in HIV and COVID-19 related studies. Their main topics of work include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • COVID-19 Clinical Research Studies
  • HIV-related health complications and treatments
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction

Frequent publication venues for their work include:

  • UNC Libraries
  • Clinical Infectious Diseases
  • JAIDS Journal of Acquired Immune Deficiency Syndromes
  • Open Forum Infectious Diseases
  • AIDS

They have collaborated regularly with several co-authors, including:

  • Jonathan Z. Li
  • Mathias Lichterfeld
  • Joseph J. Eron
  • Athe Tsibris
  • Roger Shapiro

Representative recent papers authored or co-authored by Daniel R. Kuritzkes include:

  • "SARS-CoV-2 viral load is associated with increased disease severity and mortality" (2020, Nature Communications)
  • "Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications" (2022, Clinical Pharmacology & Therapeutics)
  • "Determination of RNA structural diversity and its role in HIV-1 RNA splicing" (2020, Nature)
  • "Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis" (2021, AIDS)
  • "Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19" (2021, JAMA)

Daniel R. Kuritzkes has been recognized as a Member of the Association of American Physicians. This membership indicates engagement with a professional community in the medical field.

Best Publications

  • Update of the Drug Resistance Mutations in HIV-1.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

    Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner

  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes

  • SARS-CoV-2 viral load is associated with increased disease severity and mortality.

    Jesse Fajnzylber;James Regan;Kendyll Coxen;Heather Corry

  • Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

    Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer

  • HIV viral load markers in clinical practice

    M S Saag;M Holodniy;D R Kuritzkes;W A O'Brien

  • Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

    M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  • Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

    Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten

  • Workshop on HIV Infection and Aging: What Is Known and Future Research Directions

    Rita B. Effros;Courtney V. Fletcher;Kelly Gebo;Jeffrey B. Halter

  • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

    Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

    Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  • Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

    Joseph J. Eron;Sharon L. Benoit;Joseph Jemsek;Rodger David MacArthur

  • Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

    Michael Marcel Lederman;Elizabeth Connick;Alan Landay;Daniel R. Kuritzkes

  • Update of the Drug Resistance Mutations in HIV-1: 2005.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.

    A J Japour;D L Mayers;V A Johnson;D R Kuritzkes

  • HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.

    Robert W. Shafer;Soo-Yon Rhee;Deenan Pillay;Veronica Miller

  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

    Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

Frequent Co-Authors

Victoria A. Johnson
Victoria A. Johnson University of Alabama at Birmingham
Jonathan Z. Li
Jonathan Z. Li Brigham and Women's Hospital
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Roy M. Gulick
Roy M. Gulick Cornell University
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Utkan Demirci
Utkan Demirci Stanford University
John W. Mellors
John W. Mellors University of Pittsburgh
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career paths. Many programs offer accelerated routes, especially for students transitioning into healthcare. For example, accelerated BSN programs for non nurses provide a fast track to becoming registered nurses, which can be a valuable foundation for immunology-related roles.

Entry-level options like easy LPN programs to get into allow students to start clinical work sooner, gaining essential hands-on experience. This practical exposure is beneficial when pursuing advanced immunology studies or related healthcare careers.

For professionals aiming to specialize further, understanding which nurse practitioner program is easiest to enroll in can help streamline advancement. Nurse practitioner degrees build critical skills needed in immunology-driven patient care and research.

Specifically, top PMHNP programs with best clinical placement rates offer excellent opportunities for specialization in psychiatric mental health nursing, which often intersects with immunological health in holistic patient treatment approaches.

Exploring these programs online provides flexibility while advancing your career in healthcare and immunology fields. Leveraging these pathways can enhance both education and employment prospects.

Best Scientists Citing Daniel R. Kuritzkes

Trending Scientists

Recently Published Articles